🇺🇸 FDA
Patent

US 9371336

Compounds for treating spinal muscular atrophy

granted A61PA61P19/00A61P21/00

Quick answer

US patent 9371336 (Compounds for treating spinal muscular atrophy) held by PTC THERAPEUTICS, INC. expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P19/00, A61P21/00, A61P43/00